A Phase 2A, Double-blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Saroglitazar Magnesium 4 mg Tablets for Treating Nonalcoholic Fatty Liver Disease (NAFLD) in Women With Polycystic Ovary Syndrome (PCOS)

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 20-0589

More information available at ClinicalTrials.gov: NCT03617263

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers